Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Breast Cancer Immunotherapy: Current and Novel Approaches Publisher Pubmed



Barzaman K1, 2, 6 ; Moradikalbolandi S2 ; Hosseinzadeh A2 ; Kazemi MH1, 3 ; Khorramdelazad H1, 4, 5 ; Safari E1, 6 ; Farahmand L2
Authors

Source: International Immunopharmacology Published:2021


Abstract

The crucial role of the immune system in the progression/regression of breast cancer (BC) should always be taken into account. Various immunotherapy approaches have been investigated for BC, including tumor-targeting antibodies (bispecific antibodies), adoptive T cell therapy, vaccines, and immune checkpoint blockade such as anti-PD-1. In addition, a combination of conventional chemotherapy and immunotherapy approaches contributes to improving patients’ overall survival rates. Although encouraging outcomes have been reported in most clinical trials of immunotherapy, some obstacles should still be resolved in this regard. Recently, personalized immunotherapy has been proposed as a potential complementary medicine with immunotherapy and chemotherapy for overcoming BC. Accordingly, this review discusses the brief association of these methods and future directions in BC immunotherapy. © 2021
2. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
3. Immunotherapy for Breast Cancer Treatment, Iranian Biomedical Journal (2021)
Experts (# of related papers)
Other Related Docs
6. Breast Cancer: Biology, Biomarkers, and Treatments, International Immunopharmacology (2020)
9. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
10. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
11. Monoclonal Antibodies for Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
13. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
16. Tumor Immunology, Clinical Immunology (2022)
18. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
19. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)